Cas 1025029-35-9,cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-L-phenylalaninate

1025029-35-9

Post Buying Request

Basic information

Product Name: cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-L-phenylalaninate
Synonyms: cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-L-phenylalaninate
CAS NO:1025029-35-9
Molecular Formula:
Molecular Weight: 518.596
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-L-phenylalaninate(CAS DataBase Reference)
NIST Chemistry Reference: cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-L-phenylalaninate(1025029-35-9)
EPA Substance Registry System: cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-L-phenylalaninate(1025029-35-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1025029-35-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1025029-35-9 Suppliers

Recommended suppliers

1025029-35-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1025029-35-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,5,0,2 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1025029-35:
(9*1)+(8*0)+(7*2)+(6*5)+(5*0)+(4*2)+(3*9)+(2*3)+(1*5)=99
99 % 10 = 9
So 1025029-35-9 is a valid CAS Registry Number.

1025029-35-9Upstream product

1025030-51-6 cyclopentyl 4-{6-amino-8-[(1,3-benzodioxol-5-yl)thio]-9H-purin-9-yl}-N-(tert-butoxycarbonyl)-L-phenylalaninate

1025029-35-9Downstream Products

1025029-35-9Relevant academic research and scientific papers

ADENINE DERIVATIVES AS INHIBITORS OF HSP90 FOR THE TREATMENT OF CANCER

-

Page/Page column 75, (2008/12/05)

The invention provides a compound which is (a) an amino acid derivative of formula (I) or a tautomer thereof, or (b) a pharmaceutically acceptable salt, N-oxide, hydrate or solvate thereof: wherein R1, R2, L1, Het, A, x, y and W are as defined herein. The compounds are useful in the treatment of diseases mediated by HSP90.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1025029-35-9